Orally disintegrating tablets: A review

Tropical Journal of Pharmaceutical Research

Volumn 8, Issue 2, 2009, Pages 161-172

  Hirani, Jaysukh J ^a   Rathod, Dhaval A ^a   Vadalia, Kantilal R ^b  

^a Smt R D Gardi B Pharmacy College   (India)

^b Shri HNShukla College of Pharmacy   (India)

Author keywords

Improved bioavailability; Nanomelt ; Orally disintegrating tablet; Texture analyser

Indexed keywords

BENZOCAINE; DEXTROMETHORPHAN; DIPHENHYDRAMINE; MENTHOL; OLANZAPINE; PECTIN; SIMETHICONE;

DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG SOLUBILITY; FREEZE DRYING; HUMAN; ORALLY DISINTEGRATING TABLET; PALATABILITY; PATIENT INFORMATION; REVIEW; TABLET; TABLET DISINTEGRATION; WETTABILITY;

EID: 69249147392     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v8i2.44525     Document Type: Review

References (55)

1. Shyamala B, Narmada GY. Rapid dissolving tablets: A novel dosage form. The Indian Pharmacist, 2002; 13(8): 09-12.
2. Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm, 2004; 30(5): 525-534 (Pubitemid 38821864)
3. Hanawa T, Watanabe A, Tsuchiya T, Ikoma R, Hidaka M, Sugihara M. New Oral dosage form for elderly patients: Preparation and characterization of silk fibroin gel. Chem Pharm Bull, 1995; 43(2): 284-288.
4. Mallet L. Caring for the Elderly Patient. J. Am. Pharm. Assoc, 1996; 36(11): 628-635.
5. Porter SC. Novel drug delivery: Review of recent trends with oral solid dosage forms. Am Pharm Rev, 2001; 85: 28-35.
6. Sreenivas SA, Dandagi PM, Gadad AP, Godbloe AM, Hiremath SP, Mastiholimath VS. Orodispersible tablets: New-fangled drug delivery systems - A review. Indian J Pharm Educ Res, 2005; 39(4): 177-181.
7. Seager H. Drug-delivery products and Zydis Fastdissolving dosage form. J Pharm Pharmacol, 1998; 50: 375-382. (Pubitemid 28197414)
8. Bradoo R, Shahani S, Deewan B, Sudarshan S. Fast dissolving drug delivery system. J Am Med Assoc India, 2001; 4 (10): 27-31.
9. Mizumoto T, Masuda Y, Takeshi Y, Estuo Y, Katsuhide T. Formulation design of a novel fastdisintegrating tablet. Int J Pharm, 2005; 306(1-2): 83-90. (Pubitemid 41643142)
10. Deepak K. Orally disintegrating tablets. Tablets and Capsules, 2004; 7: 30-35.
11. Brown D. Orally disintegrating tablets: Taste over speed. Drug Deliv Tech, 2001; 3(6): 58-61.
12. US Food and Drug Administration, CDER Data Standards Manual. 2003. http://www.fda.gov/ cder/dsm/DRG/drg00201.htm. Accessed 6 February 2007.
13. European Directorate for quality of Medicines. Pharmaeuropa. 1998; 10(4): 547. http://www.pheur.org. Accessed 6 February 2007.
14. Ghosh TK, Chatterjee DJ, Pfister WR. Quick dissolving oral dosage forms: Scientific and regulatory considerations from a clinical pharmacology and biopharmaceutical perspective. In: Ghosh TK and Pfister WR (Eds). Drug Delivery to the Oral Cavity: Molecules to Market. NY, USA: CRC Press, 2005, pp 337-356.
15. Dobetti L. Fast-melting tablets: Developments and technologies. Pharm Tech, 2000; 12(9): 32-42.
16. Pather SI, Khankari R, Siebert J. Quick-dissolving intraoral tablets. In: Ghosh TK, Pfister WR (Eds). Drug Delivery to the Oral Cavity: Molecules to Market. NY, USA: CRC Press, 2005, pp 291-336.
17. Slowson M, Slowson S. What to do when patients cannot swallow their medications. Pharm Times, 1985; 51: 90-96.
18. Doheny K. You really expect me to swallow those horse pills? Am Druggist, 1993; 208: 34-35.
19. Chang RK, Guo X, Burnside BA, Couch RA. Fast dissolving tablets. Pharm Tech, 2000; 24:52-58.
20. Bogner RH, Wilkosz MF. Fast dissolving tablet. http://www.uspharmacist. com/oldformat.asp?url =newlook/files/feat/fastdissolving.htm. Accessed 16 May 2008.
21. Yarwood R. Zydis - A novel fast dissolving dosage form. Man Chem, 1990; 61:36-37.
22. Pfister WR, Ghosh TK. Orally Disintegrating Tablets: Products, Technologies and Development issues. Pharm Tech, 2005; October: 136-150.
23. Biradar SS, Bhagavati ST, Kuppasad IJ. Fast dissolving drug delivery system: A brief overview. http://www.ispub.com/ostia/index.php?xmlFileP ath=journals/ijpharm/vol4n2/drug.xml Accessed 20 January, 2006.
24. Harmon TM. Orally disintegrating tablets: A valuable life a cycle management strategy. http://www.PharmaceuticalCommerce.com. Accessed 6 February, 2008.
25. Reddy LH, Ghosh BR. Fast dissolving drug delivery systems: A review of the literature. Ind J Pharm Sci, 2002; 64(4): 331-336.
26. Aurora J, Pathak V. Oral disintegrating technologies: Oral disintegrating dosage forms: An overview. Drug Deliv Technol, 2005; 5(3): 50-54.
27. Hamilton EL, Luts EM. Advanced Orally disintegrating tablets bring significant benefits to patients and product life cycle. Drug Deliv Technol, 2005; 5(1): 34-37.
28. Habib W, Khankari R, Honts J. Fast dissolving drug delivery systems. Crt Rev Ther Drug Carrier Syst, 2000; 17(1): 61-72. (Pubitemid 30174149)
29. Lies MC, Atherton AD, Copping NM. Freeze-dried dosage forms and methods for preparing same. US Patent 5,188,825 (1993).
30. Sugihara M, Hidaka M, Saitou A. Discriminatory features of dosage form and package. Jpn J Hosp Pharm, 1986; 12: 322-328.
31. Pfister WR, Ghosh TK. Intraoral delivery systems: An overview, current status and future trends. In: Pfister WR, Ghosh TK (Eds). Drug delivery to the oral cavity: Molecules to Market. CRC Press, NY, USA, 2005, 1-40.
32. Ostrander K. Advances in fast dispersing technologies-zydis. Paper presented at the Annual Meeting of the AAPS, Salt Lake City, UT, 29 Oct., 2003.
33. th Annual Meeting of the Dysphagia Research Society, San Francisco, CA, 2-4 Oct., 2003, Dysphagia, 2005; 20(1):77-86.
34. Sharma S. New generation of tablet: fast dissolving tablet. http://www.pharmainfo.net. Accessed 15 March 2008.
35. Kuchekar BS, Bhise SB, Arumugam V. Design of fast dissolving tablets. Ind J Pharm Edu, 2001; 35: 150-152.
36. Patricia VA. Outsourcing solid-dosage manufacturing. Pharm Tech, 2006; 30 (6): 44-52.
37. Patricia VA. Advancing ODT technology. Pharm Tech, 2007; 31(10): 31-35.
38. Kelly Martin G. Orally disintegrating tablet (ODT) - NanomeltTM. http://www.ElanNanoCrystal-Technology.htm. Accessed 15 March 2008.
39. Bi Y. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull, 1996; 44: 2121-2127. (Pubitemid 26396765)
40. Bi Y. Evaluation of rapidly disintegrating tablets prepared by direct compression method. Drug Dev Ind Pharm, 1999: 25(5): 571-581. (Pubitemid 29186288)
41. El-Arini SK, Clas SD. Evaluation of disintegration testing of different fast dissolving tablets using texture analyzer. Pharm Dev Technol, 2002; 7(3): 361-371.
42. Klancke J. Dissolution testing of orally disintegrating tablets. Dissolution Technol, 2003; 10(2): 6-8.
43. Amin AF, Shah TJ, Bhadani MN, Patel MM. Emerging trends in the development of orally disintegrating tablet technology. http://www.pharmainfo. net Accessed 6 February 2007.
44. Wilson CG, Washington N, Peach J, Murray GR, Kennerley J. The behaviour of a fast-dissolving dosage form (Expidet) followed by gscintigraphy. Int J Pharm, 1987; 40:119-123.
45. Wilson CG, Washington N, Norman S, Greaves JL, Peach JM, Pugh K. A gamma scintigraphic study to compare esophageal clearance of expidet formulations, tablets and capsules in supine volunteers. Int J Pharm, 1988; 46: 241-246. (Pubitemid 18233558)
46. Washington N, Wilson CG, Greaves JL, Norman S., Peach JM, Pugh K. A gamma scintigraphic study of gastric coating by expidet tablet and liquid formulations. Int J Pharm, 1989; 57: 17-22. (Pubitemid 20017859)
47. Smith GB, Huges DG, Kumar V. Temazepam in fast dispensing dosage form as a pre-medication for children. Anaesthesia, 1985; 40: 368-371. (Pubitemid 15114315)
48. Schroeder HG. The use of temazepam expidet (FDDF) as a pre-medicant in children. Acta Psychiatr Scand Suppl, 1986; 332: 167-171.
49. Barrett RF. James PD, Macleod KC. Oxazepam premedication in neurosurgical patients. Anaesthesia, 1984; 39: 429-432.
50. Brampton WJ, Plantevin OM. Double-blind crossover study of the efficacy and acceptability of oxazepam expidet tablets compared to placebo in patients undergoing gynaecological surgery. Int Med Res, 1985; 13 (3): 169-173.
51. Bruna E, Leneveu A, Abouchaera ML, Delhotal B, Chauveau C, Rayot F, Fouvat B. Acetaminophen flashtab formulation: fast disintegration and optimal absorption of the active ingredient. Proc Intl Symp Control Rel Bioact Mater, 1998; 25: 938-939. (Pubitemid 28336915)
52. Dollo G, Chevanne F, Le Corre P, Chemtob C, Le Verge R. Bioavailability of phloroglucinol in man. J Pharm Belg, 1999; 54 (3): 75-82.
53. Jaccard TT, Leyder J. Une Nouvelle Forme Galenique. Ann Pharm Fr, 1885; 43 (2): 123-131.
54. Gafitanu E, Dumistracel I, Antochi S. Formulations and bioavailability of propyphenazone in lyophilized tablets. Rev Med Chir Soc Med Nat Iasi, 1991; 95 (1-2): 127-128.
55. Guillard O, Huguet F, Fauconneau B, Piriou A, Pineau A. Absence of gastrointestinal absorption or urinary excretion of aluminium from an allantoinate complex contained in two antacid formulations in patients with normal renal function. Eur J Clin Chem Clin Biochem, 1996; 34 (8): 609-612. (Pubitemid 26293747)